Fremont, CA, United States of America

Jay Wei

This inventor holds 37 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 9 EPO patents, primarily in Optical Coherence Tomography. Top assignees: Carl Zeiss Gmbh, Optovue, Inc., Carl Zeiss Meditec Gmbh. Active years: 1995-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jay Wei. Retrieved from https://idiyas.com/inventor/jay-wei

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 37 

% Patents Active = 75.7

 

 

Average Co-Inventor Count = 2.3

ph-index = 22

Forward Citations = 2,399(Granted Patents)


Company Filing History:


Years Active: 1995-2021

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
OCT Angiography
Eye Measurements
Artifact Reduction
Visual Field Tester
Corneal Profile
Wavefront Measurement
Eye Disease Monitoring
Surgical Apparatus
Biometry
Interferometry
Eye Registration
Optical Aberrations
37 patents (USPTO):Explore Patents

Title: Jay Wei: Innovator in Retina Blood Vessel Assessment Technologies

Introduction

Jay Wei, a prominent inventor based in Fremont, CA, has made substantial contributions to the field of optical coherence tomography (OCT) with a notable portfolio of 37 patents. His work primarily focuses on innovative methods and apparatus for assessing retina blood vessels, demonstrating his commitment to enhancing medical imaging technologies and patient care.

Latest Patents

Wei's latest patents describe sophisticated techniques in retina blood vessel assessment utilizing OCT angiography. One of these patents details a method where an OCT angiography image representation is created, assigning respective values to OCTA pixels. From this data, a vessel density map is computed, allowing for the generation of a fractional deviation map and a pattern deviation map. These maps enable clinicians to assess the percent loss of vessel density at each pixel location compared to normative databases, providing critical insights for patient diagnoses.

Another innovative patent outlines a methodology for processing a 3D OCT dataset, which includes obtaining OCT data and employing segmentation techniques. This methodology advances the field by producing image representations through careful pixel value assignments, ultimately enhancing the clarity and effectiveness of retinal assessments.

Career Highlights

Throughout his career, Jay Wei has contributed his expertise to esteemed organizations such as Carl Zeiss GmbH and Optovue, Inc. His roles in these companies have allowed him to push the boundaries of optical technologies and reinforce his status as a leading inventor in the field.

Collaborations

In his professional journey, Wei has had the pleasure of collaborating with notable colleagues, including Ben Jang and Thomas Hellmuth. Their teamwork has likely contributed to the innovative advancements in the projects they've undertaken, fostering a collaborative environment centered around revolutionary medical imaging solutions.

Conclusion

Jay Wei stands out as a visionary inventor, with a robust portfolio of patents that significantly impact the medical imaging landscape. His innovative approaches to retina blood vessel assessment through optical coherence tomography exemplify the intersection of technology and healthcare, driving advancements that ultimately enhance patient outcomes. With continued dedication to his craft, Wei's contributions will likely inspire future innovations in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…